Wyatt RJ - Search Results

1

Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.

Egan MF, Hyde TM, Kleinman JE, Wyatt RJ. Egan MF, et al. Among authors: wyatt rj. Psychopharmacology (Berl). 1995 Jan;117(1):74-81. doi: 10.1007/BF02245101. Psychopharmacology (Berl). 1995. PMID: 7724705

2

Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum.

Egan MF, Karoum F, Wyatt RJ. Egan MF, et al. Among authors: wyatt rj. Eur J Pharmacol. 1991 Jun 25;199(2):191-9. doi: 10.1016/0014-2999(91)90457-2. Eur J Pharmacol. 1991. PMID: 1954977

3

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.

Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE. Egan MF, et al. Among authors: wyatt rj. Synapse. 1994 Nov;18(3):178-89. doi: 10.1002/syn.890180303. Synapse. 1994. PMID: 7531873

4

Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.

Hyde TM, Egan MF, Wing LL, Wyatt RJ, Weinberger DR, Kleinman JE. Hyde TM, et al. Among authors: wyatt rj. Psychopharmacology (Berl). 1995 Mar;118(2):142-9. doi: 10.1007/BF02245832. Psychopharmacology (Berl). 1995. PMID: 7617800

5

Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.

Knable MB, Hyde TM, Egan MF, Tosayali M, Wyatt RJ, Kleinman JE. Knable MB, et al. Among authors: wyatt rj. Brain Res. 1994 May 23;646(2):217-22. doi: 10.1016/0006-8993(94)90081-7. Brain Res. 1994. PMID: 8069667

6

Basal ganglia iron in tardive dyskinesia: an MRI study.

Elkashef AM, Egan MF, Frank JA, Hyde TM, Lewis BK, Wyatt RJ. Elkashef AM, et al. Among authors: wyatt rj. Biol Psychiatry. 1994 Jan 1;35(1):16-21. doi: 10.1016/0006-3223(94)91161-4. Biol Psychiatry. 1994. PMID: 8167198

7

The effects of acute and chronic haloperidol treatment on dopamine release mediated by the medial forebrain bundle in the striatum and nucleus accumbens.

Egan MF, Chrapusta SJ, Karoum F, Wyatt RJ. Egan MF, et al. Among authors: wyatt rj. Neuropsychopharmacology. 1996 Mar;14(3):211-23. doi: 10.1016/0893-133X(95)00111-P. Neuropsychopharmacology. 1996. PMID: 8866705

8

Treatment of tardive dyskinesia.

Egan MF, Apud J, Wyatt RJ. Egan MF, et al. Among authors: wyatt rj. Schizophr Bull. 1997;23(4):583-609. doi: 10.1093/schbul/23.4.583. Schizophr Bull. 1997. PMID: 9365997 Review.

9

Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.

Apud JA, Egan MF, Wyatt RJ. Apud JA, et al. Among authors: wyatt rj. Schizophr Res. 2003 Sep 1;63(1-2):151-60. doi: 10.1016/s0920-9964(02)00338-9. Schizophr Res. 2003. PMID: 12892869

10

Treatment of tardive dyskinesia with vitamin E.

Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ. Egan MF, et al. Among authors: wyatt rj. Am J Psychiatry. 1992 Jun;149(6):773-7. doi: 10.1176/ajp.149.6.773. Am J Psychiatry. 1992. PMID: 1350428 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters